Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7071-7078

  Zhong, Weixiong ^a   Oberley, Terry D ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; PROTEIN P21; SELENIUM; SODIUM SELENITE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CHRONICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GROWTH INHIBITORS; HUMANS; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; PROSTATIC NEOPLASMS; SODIUM SELENITE; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035476847     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Selenium: Biochemical role as a component of glutathione peroxidase
2. Selenium and the thioredoxin redox system: Effects on cell growth and death
3. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium
4. Prophylaxis of mammary neoplasia by selenium supplementation in the iniation and promotion phases of chemical carcinogenesis
5. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells
6. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
7. 2 cells
8. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality
9. Cancer mortality correlation studies. III. Statistical association with dietary selenium intakes
10. Selenium in forage crops and cancer mortality in US countries
11. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
12. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China
13. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
14. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
15. Cancer statistics. 2000
16. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro
17. Effects of selenium in combination with adriamycin or taxol on several different cancer cells
18. Selenium effects on prostate cell growth
19. Chemopreventive agents: Selenium
20. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
21. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake
22. Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes
23. Oxygen radicals and signaling
24. Regulation of gene expression by reactive oxygen
25. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro
26. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells
27. Redox regulation of fos and jun DNA-binding activity in vitro
28. Modulation of transcription factor NF-κ B binding activity by oxidation-reduction in vitro
29. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
30. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity
31. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α
32. In vitro growth and differentiation of human kidney tubular cells on a basement membrane substrate
33. Inhibition of cell growth in NIH/3T3 fibroblasts by overexpression of manganese superoxide dismutase: Mechanistic studies
34. Glutathione peroxidase activity in selenium-deficient rat liver
35. Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells
36. Assays of cell viability: Discrimination of cells dying by apoptosis
37. Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle
38. Selenium and prostate cancer prevention
39. Mitochondria and apoptosis
40. Immunolocalization of antioxidant enzymes in adult hamster kidney
41. Role of superoxide dismutase in cancer: A review
42. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells
43. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase
44. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase
45. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells
46. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype
47. 2O2
48. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κ B and activated protein-1
49. Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
50. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention
51. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways
52. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
53. waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs
54. 2 DNA damage checkpoint
55. 2/M arrest, and apoptosis
56. 2/M arrest by the isoflavone genistein in human prostate carcinoma cells